Prosthetic Aortic Valve and Root Endocarditis
Prosthetic aortic valve endocarditis is a progressive and serious disease. Today, with good diagnostic methods, antibiotic regimens, and improved surgical techniques and experience, most patients are expected to survive and be cured. Cure requires prompt and aggressive diagnosis, optimal antibiotic treatment, and, most often, well-timed and executed surgery. These operations are difficult and require experience, as illustrated by the wide variations in outcomes in different series. Operations for prosthetic valve endocarditis (PVE) require understanding of the pathology and familiarity with all the tools necessary to reconstruct the heart.
KeywordsCatheter Perforation Gentamicin Candida Staphylococcus
- 2.American College of Cardiology/American Heart Association Task Force on Practice Guideline; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84–231. Erratum in: Circulation. 2007;115:e409.Google Scholar
- 7.Olaison L, Pettersson G. Current best practices and guidelines: indications for surgical intervention in infective endocarditis. Infect Dis Clin N Am 2002;16:453–75 and Cardiol Clin 2003;21:235–51.Google Scholar
- 9.Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS; ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005;293:3012–21. Erratum in: JAMA 2005;294:900.Google Scholar
- 10.Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications. Circulation 2005;111:e394–433. Erratum in: Circulation. 2005;112:2373.Google Scholar